Burns — The FAB Score Inter-rater Reliability Study
Citation(s)
Eagan JH, Ramdharry G, Smailes ST Investigating the interrater reliability of a novel functional outcome measure for use in the burns intensive care unit: The Functional Assessment for Burns - Critical Care (FAB-CC). Burns. 2020 Mar;46(2):279-285. doi: 10.1016/j.burns.2018.12.004. Epub 2018 Dec 27.
Smailes ST, Engelsman K, Dziewulski P Physical functional outcome assessment of patients with major burns admitted to a UK Burn Intensive Care Unit. Burns. 2013 Feb;39(1):37-43. doi: 10.1016/j.burns.2012.05.007. Epub 2012 Jun 6.
Smailes ST, Engelsman K, Rodgers L, Upson C Increasing the utility of the Functional Assessment for Burns Score: Not just for major burns. Burns. 2016 Feb;42(1):163-168. doi: 10.1016/j.burns.2015.09.020. Epub 2015 Oct 25.
Investigating the Inter-rater Reliability of the Functional Assessment for Burns (FAB) Score in Adult Burn Inpatients
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
